Cargando…
Partial loss of genes might open therapeutic window
The loss of genes that encode RNA splicing factors weakens cancer cells in a way that could be exploited by new approaches to treatment.
Autores principales: | Liu, Bo, Abdel-Wahab, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357136/ https://www.ncbi.nlm.nih.gov/pubmed/28304277 http://dx.doi.org/10.7554/eLife.25996 |
Ejemplares similares
-
Pathology of healing: what else might we look at?
por: Horimoto, Yoshiya, et al.
Publicado: (2016) -
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
por: Paolella, Brenton R, et al.
Publicado: (2017) -
A window-of-opportunity biomarker study of etodolac in resectable breast cancer
por: Schwab, Richard B, et al.
Publicado: (2015) -
Neural stem cell-encoded temporal patterning delineates an early window of malignant susceptibility in Drosophila
por: Narbonne-Reveau, Karine, et al.
Publicado: (2016) -
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)